Myeloma XI study: Quadruplet regimen for transplant eligible patients

Developments in CAR T treatments for adult patients

Outcomes for patients with disease progression following CD19-specific CAR T-cell therapy

ASH 2018: Expert overview of the latest in CLL, ALL and AML

Updates on the ELIANA trial for acute lymphocytic leukaemia in young patients

Determining the prognosis of patients with myelodysplastic syndromes using machine learning

The benefits of a stem cell transplant after CAR T-cell therapy in paediatric patients

Long term data from JULIET trial, using tisagenlecleucel for patients with relapsed or treatment-resistant DLBCL

Link between gut microbiota and haematopoietic cell transplantation outcomes

Progression-free survival milestones in primary central nervous system lymphoma

New therapies for transfusion dependent MDS patients

Stem cell transplant after CAR T-cell therapy reduces relapses in acute lymphocytic leukaemia